Location History:
- Schliengen, DE (1995 - 1997)
- Freiburg, DE (1998)
Company Filing History:
Years Active: 1995-1998
Title: Innovations of Claus G Riemer in Water Soluble Taxol Derivatives
Introduction
Claus G Riemer is a notable inventor based in Schliengen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of water soluble taxol derivatives. With a total of 3 patents to his name, Riemer's work has the potential to impact cancer treatment methodologies.
Latest Patents
Riemer's latest patents focus on alkaline sensitive protaxol, which is water soluble and hydrolyzed at physiological (alkaline) pH to restore the native taxol structure and activity. The protaxol compositions include 2'- and/or 7-O-ester derivatives of taxol and/or 2'- and/or 7-O-carbonate derivatives of taxol. The chemical formula for protaxol includes various radicals and components that enhance its solubility and efficacy in medical applications.
Career Highlights
Riemer is associated with The Scripps Research Institute, where he has been involved in groundbreaking research. His work has contributed to advancements in drug formulations that are crucial for effective cancer therapies.
Collaborations
Some of Riemer's notable coworkers include K C Nicolaou and Michael A Kerr, who have collaborated with him on various research projects.
Conclusion
Claus G Riemer's innovations in water soluble taxol derivatives represent a significant advancement in pharmaceutical research. His contributions are poised to enhance the effectiveness of cancer treatments and improve patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.